Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Rapport Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit (3) |
Maximum Aggregate Price (3) |
Fee Rate |
Amount of Registration Fee |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial Effective Date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to Be Paid |
Equity | Common Stock, $0.001 par value per share |
457(c) | 470,589 | $11.54 | $5,430,597.06 | 0.00015310 | $831.43 | | | | | ||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities |
| | | | | | | | | | | | ||||||||||||
Total Offering Amounts | $5,430,597.06 | $831.43 | ||||||||||||||||||||||
Total Fees Previously Paid | | |||||||||||||||||||||||
Total Fee Offsets | | |||||||||||||||||||||||
Net Fee Due | $831.43 |
(1) | The registrant is hereby registering for resale or other disposition, from time to time, by the selling stockholder (the selling stockholder) named in the prospectus that forms a part of this registration statement (this registration statement) an aggregate of up to 470,589 shares of the registrants common stock, par value $0.001 per share (common stock). Pursuant to Rule 416 under the Securities Act of 1933, as amended (the Securities Act), this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement. |
(2) | Represents the maximum number of shares of common stock that may be offered and sold, from time to time, by the selling stockholder, which shares were issued to the selling stockholder in a private placement transaction. |
(3) | Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act. The price per share and aggregate offering price are based on the average of the high and low prices of the registrants common stock on June 27, 2025, as reported on The Nasdaq Global Market. |